Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2010 - 2026)

Jazz Pharmaceuticals' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $6.0 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 7.25% year-over-year to $6.0 billion; the TTM figure through Mar 2026 stood at $6.0 billion (down 7.25% YoY), while the FY2025 annual figure was $6.3 billion, down 3.29% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $6.0 billion, down from $6.3 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $8.6 billion in Q1 2022, with the low at $2.5 billion in Q4 2023.
• The 5-year median for Goodwill & Intangibles is $6.9 billion (2024), against an average of $6.7 billion.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles soared 287.08% in 2022, then plunged 66.53% in 2023.
• Jazz Pharmaceuticals' Goodwill & Intangibles stood at $7.5 billion in 2022, then slumped by 66.53% to $2.5 billion in 2023, then jumped by 158.3% to $6.5 billion in 2024, then fell by 3.29% to $6.3 billion in 2025, then slipped by 3.99% to $6.0 billion in 2026.
• Business Quant data shows JAZZ's Goodwill & Intangibles at $6.0 billion in Q1 2026, $6.3 billion in Q4 2025, and $6.4 billion in Q3 2025.